Professor of Obstetrics and Gynecology, Mayo Medical School
Obstetrics & Gynecology
Dr. William A. Cliby, MD
|
|
Give Review
William Cliby practices Obstetrics & Gynecology. He researched medicine at University of Vermont College of Medicine. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Fellow (FACS)" and "Fellow (FACOG)". William A. Cliby, MD is a published physician. He has 101 publications published. The most current publication "Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures." Dr. William A. Cliby accepts Medicare.
Publications
- Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial Carcinoma and limited myometrial invasion.
- The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial Cancer cohorts.
- Performance of AGO score for secondary cytoreduction in a high-volume U.S. center.
- Incorporating robotic-assisted surgery for endometrial Cancer staging: Analysis of morbidity and costs.
- Patterns of Müllerian inhibiting substance type II and candidate type I receptors in epithelial ovarian Cancer.
- Incisional Recurrences After Endometrial Cancer Surgery.
- Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian Cancer.
- Assessment of published models and prognostic variables in epithelial ovarian Cancer at Mayo Clinic.
- Lymphatic mapping and ligation for persistent ascites after surgery for gynecologic malignancy.
- Detection of circulating tumor cells in high-risk endometrial Cancer.
- Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian Cancer.
- Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous Carcinoma.
- Surgical site infection after primary surgery for epithelial ovarian Cancer: Predictors and impact on survival.
- Ovarian Cancer in the United States: Contemporary patterns of care associated with improved survival.
- Impact of obesity on surgical and oncologic outcomes in ovarian Cancer.
- Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian Cancer.
- Effect of Tubal Sterilization Technique on Risk of Serous Ovarian and Primary Peritoneal Carcinoma.
- Management of epithelial ovarian Cancer in the setting of concomitant venous thromboembolism.
- Short-term outcomes after incontinent conduit for gynecologic Cancer: Comparison of ileal, sigmoid, and transverse colon.
- Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial Cancer.
- Role of pelvic and para-aortic lymphadenectomy in endometrial Cancer: Current evidence.
- Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial Cancer.
- Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial Cancer.
- Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid Cancer.
- Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and Cervical cancer is low: a multi-institutional study.
- Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial Cancer.
- The use of CT findings to predict extent of tumor at primary surgery for ovarian Cancer.
- We need a new paradigm in gynecologic Cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.
- Multiple large bowel resections: Potential risk factor for anastomotic leak.
- Predictors and costs of surgical site infections in patients with endometrial Cancer.
- Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status.
- Nutritional status, CT body composition measures and survival in ovarian Cancer.
- Vulvar and Vaginal melanoma: Case series and review of current management options including neoadjuvant chemotherapy.
- Metformin intake is associated with better survival in ovarian Cancer: A case-control study.
- Factors predictive of postoperative morbidity and cost in patients with endometrial Cancer.
- Risk factors for developing endometrial Cancer after benign endometrial sampling.
- Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial Cancer.
- Impact of the new FIGO 2009 staging classification for vulvar Cancer on prognosis and stage distribution.
- Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian Carcinoma.
- RE: Defining the limits of radical cytoreductive surgery in ovarian Cancer.
- The impact of surgical guidelines and periodic quality assessment on the staging of endometrial Cancer.
- Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian Cancer: Implications for surgical staging.
- Intraoperative Imaging in Ovarian Cancer: Fact or Fiction?
- Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian Cancer.
- Comparison of gene expression patterns between avian and human ovarian Cancers.
- Identification of patient groups at highest risk from traditional approach to ovarian Cancer treatment.
- Pathologic characteristics of hysterectomy specimens in women undergoing hysterectomy after global endometrial ablation.
- Analysis of outcomes of microinvasive adenoCarcinoma of the uterine cervix by treatment type.
- Is there a high-risk subgroup of stage I epithelial ovarian Cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?
- The National Cancer Database report on advanced-stage epithelial ovarian Cancer: impact of hospital surgical case volume on overall survival and surgical treatment par...
- Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and syst...
- The impact of multi-modal therapy on survival for Uterine carcinosarcomas.
- Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculec...
- Improving quality of care: development of a risk-adjusted perioperative morbidity model for Vaginal hysterectomy.
- Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian Cancer.
- Inherited determinants of ovarian Cancer survival.
- Efficacy of bipolar radiofrequency endometrial ablation vs thermal balloon ablation for management of menorrhagia: A population-based cohort.
- Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian Cancer after thorough exploration.
- Pattern of retroperitoneal dissemination of primary peritoneum Cancer: basis for rational use of lymphadenectomy.
- Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin.
- Quality improvement in the surgical approach to advanced ovarian Cancer: the Mayo Clinic experience.
- Stage IV ovarian Cancer: disease site-specific rationale for postoperative treatment.
- Aggressive and complex surgery for advanced ovarian Cancer: an economic analysis.
- Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian Cancer.
- Prediction of treatment outcomes after global endometrial ablation.
- Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial Cancer.
- Prospective assessment of lymphatic dissemination in endometrial Cancer: a paradigm shift in surgical staging.
- Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic Cancers.
- Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon Cancers.
- Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian Cancer.
- Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous Carcinoma.
- Role of cytoreduction in stage III and IV uterine papillary serous Carcinoma.
- Treatment of pulmonary recurrences in patients with endometrial Cancer.
- A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian Cancer using a risk-adjusted model.
- How relevant are ACOG and SGO guidelines for referral of adnexal mass?
- Epithelial ovarian Cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
- Patterns of inguinal groin metastases in squamous cell Carcinoma of the vulva.
- Global endometrial ablation for menorrhagia in women with bleeding disorders.
- Current management strategies for ovarian Cancer.
- Analysis of factors impacting operability in stage IV ovarian Cancer: rationale use of a triage system.
- Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian Cancer.
- Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian Cancer?
- Is it justified to classify patients to Stage IIIC epithelial ovarian Cancer based on nodal involvement only?
- Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian Cancer.
- Risk factors for anastomotic leak after recto-sigmoid resection for ovarian Cancer.
- Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian Cancer.
- Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
- Importance of surgical aggressiveness in advanced ovarian Cancer.
- Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial Cancer: technique and analysis of outcomes.
- Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial Cancer patients.
- Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian Cancer.
- Ovarian Cancer surgical resectability: relative impact of disease, patient status, and surgeon.
- Aggressive surgical effort and improved survival in advanced-stage ovarian Cancer.
- Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival.
- Heterozygous ATR mutations in mismatch repair-deficient Cancer cells have functional significance.
- Long-term survival and disease recurrence in patients with primary squamous cell Carcinoma of the vulva.
- Elevated fibroblast growth factor 23 in women with malignant Ovarian tumors.
- Gene expression profiles predict early relapse in ovarian Cancer after platinum-paclitaxel chemotherapy.
- Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
- Molecular classification of high grade endometrioid and clear cell ovarian Cancer using TCGA gene expression signatures.
Schools
University Of Vermont College Of Medicine
Duke University Med Center
Mayo Grad School MedMayo Fndn
Procedures Preformed
- Colpopexy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Chronic Pelvic Pain
- Endometriosis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FACS)
- Fellow (FACOG)
Education
-
Mayo School of Graduate Medical Education -
Duke University Hospital -
University of Vermont College of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205815636 |
| Last Name Of The Provider | CLIBY |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. C Robert Stanhope, MD |
|
|
Dr. Jamie N. Bakkum-Gamez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karl C. Podratz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger D. Kempers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger W. Harms, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philippe R. Housmans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica B. Jones, MD |
|
|
Dr. Bobbie S. Gostout, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosalina L. Abboud, MD |
|
|
Dr. Jack F. Perrone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brigitte A. Barrette, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle L. Delplanche, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl H. Rose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristi L. Boldt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret E. Long, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy O. Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula D. Chantigian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary C. Tolcher, MD
This Doctor is OpenDoctor Recommended.
|